News
Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This ...
Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This ...
Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 16, 2025) - Alvotech (NASDAQ: ALVO, the "Company"), a global biotech company specializing in the development and manufacture of biosimilar medicines ...
REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 19, 2025) - Alvotech (NASDAQ: ALVO, the "Company”) has entered into agreement with DNB Carnegie Investment Bank AB (publ) ("DNB Carnegie”) regarding ...
Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...
Teva and Alvotech announced that the U.S. Food and Drug Administration (FDA) approved SELARSDI (ustekinumab-aekn) injection as ...
REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 8, 2025) - Alvotech (NASDAQ: ALVO, the "Company"), a global biotech company specializing in the development and manufacture of biosimilar medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results